RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 89-99
  • Chicago misses out in AbbVie-Calico pharma deal

     Chicago misses out in AbbVie-Calico pharma deal
    A few days ago, Calico, a Google-backed biotech company, announced that it would build a California-based research and development facility to invent new drugs to combat diseases afflicting the elderly. Half of the initial $500 million investment...
  • CytRx is pouring money into R&D of cancer-fighting drugs

    CytRx is pouring money into R&D of cancer-fighting drugs
    CytRx Corp. is on a mission to cure cancer — or at least slow it down. The Los Angeles biopharmaceutical company, which recently has become embroiled in a stock-promotion controversy, specializes in researching and developing drugs to treat...
  • U.S. seeks to speed up production of Ebola drug

    U.S. seeks to speed up production of Ebola drug
    With the Ebola outbreak threatening to spiral out of control, U.S. officials unveiled a multimillion-dollar plan Tuesday aimed at getting a promising drug out of American research labs and into African hospitals and clinics more quickly. The...
  • Hospira talks for $5 billion tax inversion deal stall

    Hospira talks for $5 billion tax inversion deal stall
    Lake Forest-based drugmaker Hospira's talks to buy the medical nutrition unit of Danone and use the deal to move its tax domicile abroad have stalled, according to people familiar with the matter, as attempts by U.S. companies to relocate abroad and cut...
  • Allergan sets shareholder meeting on hostile takeover attempt

    Allergan sets shareholder meeting on hostile takeover attempt
    Allergan Inc. scheduled a Dec. 18 special meeting of its shareholders that could ultimately resolve a hostile takeover attempt by a Canadian rival. Valeant Pharmaceuticals International Inc., which is based near Montreal, has been fighting since April...
  • Retirement: Save on prescription-drug costs

    Whether you get your prescription drugs through your employer's health plan or through a Medicare Part D plan, there are ways you can save on your medications. Keep an eye out for new generic drugs. The patents for several popular brand-name drugs --...
  • Sanford-Burnham taps new CEO from pharma industry

    Sanford-Burnham taps new CEO from pharma industry
    With the selection of Perry Nisen as its new chief executive officer today, Sanford-Burnham Medical Research Institute is signaling a commitment to its new long-term strategic vision of open collaboration for the development of breakthrough clinical...
  • Glades Drugs opening headquarters in Lake Worth

    Glades Drugs opening headquarters in Lake Worth
    Glades Drugs, a pharmacy retailer owned and operated by pharmacists, is opening new headquarters in Lake Worth. The new 8,000-square-foot location at 4560 Lantana Road will feature office space, a lab and pharmacy. Glades Drugs, now based in Boca Raton,...
  • Baxter reports success in late-stage trial on extended release hemophilia drug

    Baxter reports success in late-stage trial on extended release hemophilia drug
    Baxter International Inc. said Thursday a key hemophilia drug under development met its primary goal in a late-stage clinical study. The drug, known as BAX 855, is essentially a stronger, extended-release version of its flagship hemophilia drug Advate,...
  • Sanofi wins right to market MannKind's inhaled insulin drug Afrezza

    A French pharmaceutical company has agreed to pay up to $925 million for the right to market Afrezza, the recently approved inhaled insulin treatment for diabetes developed by MannKind Corp. of Valencia. Sanofi, based in Paris, said it would pay $150...
  • Experimental Ebola drug 'exhausted,' as experts debate ethical use

    As U.S. medical experts raised concerns Tuesday about the use of experimental drugs to treat the Ebola virus, makers of the unapproved medication ZMapp said their supply has been "exhausted." In a statement published online late Monday, Mapp...